Emergent Health Corp (EMGE)

Market Cap	42.70K -92.6%
Revenue (ttm)	119.57K -91.2%
Net Income	-288.76K
EPS	-0.00
Shares Out	426.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	488,407
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0011
Beta	-6.98
RSI	47.77
Earnings Date	n/a

About Emergent Health

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: EMGE

Financial Performance

In 2021, Emergent Health's revenue was $119,567, a decrease of -28.48% compared to the previous year's $167,191. Losses were -$288,764, 264.9% more than in 2020.